Literature DB >> 20558189

Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells.

Chunmin Dong1, Lin Yuan, Jun Dai, Ling Lai, Lulu Mao, Shulin Xiang, Brian Rowan, Steven M Hill.   

Abstract

Luciferase reporter constructs and transient co-transfection approaches demonstrate that elevated expression of RORalpha1 augments 17-beta-estradiol (E(2))-induced transcriptional activation of the full-length ERalpha, but not truncated ERalpha constructs (ABCD or CDEF), in MCF-7 breast cancer and HEK293 embryonic kidney cells, and that physiologic concentrations of MLT inhibit the individual and combined transcriptional activity of ERalpha by RORalpha1 and E(2). Gel mobility shift and co-immunoprecipitation (IP)/pull-down assays demonstrate that RORalpha1 and ERalpha do not interact directly at the DNA-binding level or as heterodimers, however, RORalpha1 augments E(2)-induced pS2 and cyclin D1 mRNA expression while MLT inhibits RORalpha1/E(2)-induced expression of pS2 and cyclin D1 in MCF-7 cells. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558189     DOI: 10.1016/j.steroids.2010.06.002

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  7 in total

Review 1.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

Review 2.  Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.

Authors:  Enrico Garattini; Marco Bolis; Maurizio Gianni'; Gabriela Paroni; Maddalena Fratelli; Mineko Terao
Journal:  Oncotarget       Date:  2016-07-05

3.  Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

Authors:  Federica Lo Sardo; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Int J Mol Sci       Date:  2017-09-06       Impact factor: 5.923

4.  Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.

Authors:  Ali Mohamed Alshabi; Ibrahim Ahmed Shaikh; Chanabasayya Vastrad
Journal:  Biomolecules       Date:  2019-07-15

5.  RORα, a potential tumor suppressor and therapeutic target of breast cancer.

Authors:  Jun Du; Ren Xu
Journal:  Int J Mol Sci       Date:  2012-11-26       Impact factor: 5.923

6.  Melatonin anticancer effects: review.

Authors:  Giuseppe Di Bella; Fabrizio Mascia; Luciano Gualano; Luigi Di Bella
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

7.  EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.

Authors:  Igor Katsyv; Minghui Wang; Won Min Song; Xianxiao Zhou; Yongzhong Zhao; Sun Park; Jun Zhu; Bin Zhang; Hanna Y Irie
Journal:  Oncotarget       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.